skip to Main Content

International Oligonucleotide and Peptides Conference

Our Director of Peptide Chemistry, Elisabetta Bianchi, will be attending and speaking at the 1st International Oligonucleotide and Peptides Conference (IOPC 2019) in Milan from September 17-18. The event will cover important and trending topics at the forefront of oligonucleotide…

Discovery on Target

Next week our Global Vice President of Sales and Marketing, Heidi Kingdon Jones, and Vice President of North American Business Development, Daniel Conlon, will be attending Discovery on Target in Boston. The conference brings the biopharma industry together to share…

Boston BD

Our Vice President of North American Business Development, Daniel Conlon, will be at the Boston BD conference on September 10. This invitation-only event brings together Biopharma thought leaders to network and explore insights into the business challenges and opportunities facing…

IRBM - First Targeted Protein Degrader Begins Phase I Clinical Trial

First targeted protein degrader begins phase I clinical trial

Despite the fact that less than 20% of the proteome has enzymatic activity, most drug development efforts have so far focused on identifying enzymatic inhibitors. However, targeting a cell’s proteasomal machinery is now considered an effective area of research. As…

DNA IRBM

CHDI Foundation extends collaboration with IRBM to accelerate development of Huntington’s disease therapeutics

Pomezia, Italy, November 19th 2018 – IRBM, a global contract research organization (CRO), has strengthened its position in neurodegenerative disease research following an extension of its long-standing collaboration with CHDI Foundation, a nonprofit biomedical research organization exclusively dedicated to collaboratively developing therapeutics that substantially improve the lives of those affected by Huntington’s disease (HD).

Medical Research IRBM

BIO-Europe 2018

November 5-7, 2018 Copenhagen, Denmark Come meet IRBM’s delegates in Copenhagen to learn more about how IRBM can support your drug discovery efforts. Drop us a line to request a meeting through our contact form or, when open, the PartneringONE…

Back To Top